Limitation-circumventing and strength-capitalizing hydrogel potentiates durable antitumor immunity and robust abscopal effect in radiotherapy
Open Access
- 1 January 2026
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 16 (3) , 1432-1444
Abstract
Background: Radiotherapy (RT)-induced antitumor immunity has attracted extensive attention. However, such antitumor immunity often proves inadequate to combat metastatic and recurrent tumors in clinical practice. While hypoxia severely limits the initiation of adequate systemic antitumor immune responses, the strength of such responses is further compromised by the blockage of effector T cells, ultimately undermining the ability of RT to elicit a robust abscopal effect and durable immune memory.Keywords
This publication has 34 references indexed in Scilit:
- Current Landscape of Immunotherapy in Breast CancerJAMA Oncology, 2019
- Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapyCancer Letters, 2019
- Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levelsBMC Cancer, 2019
- Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of CancerNano Letters, 2018
- Advances in the Systemic Treatment of Triple-Negative Breast CancerCurrent Oncology, 2018
- Targeting tumour hypoxia: shifting focus from oxygen supply to demandBritish Journal of Radiology, 2018
- Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated TherapyACS Nano, 2017
- Immunogenic cell death in cancer and infectious diseaseNature Reviews Immunology, 2016
- Radiation oncology in the era of precision medicineNature Reviews Cancer, 2016
- Hypofractionation Results in Reduced Tumor Cell Kill Compared to Conventional Fractionation for Tumors With Regions of HypoxiaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011